Efficacy and Safety of Rociletinib Versus Chemotherapy in Patients With EGFR-Mutated NSCLC: The Results of TIGER-3, a Phase 3 Randomized Study
Journal
JTO Clinical and Research Reports
Journal Volume
2
Journal Issue
2
Date Issued
2021
Author(s)
Reckamp K.L.
Kim Y.-C.
Novello S.
Smit E.F.
Lee J.-S.
Su W.-C.
Akerley W.L.
Blakely C.M.
Groen H.J.M.
Bazhenova L.
Carcereny Costa E.
Chiari R.
Hsia T.-C.
Golsorkhi T.
Despain D.
Shih D.
Popat S.
Wakelee H.
Publisher
Elsevier Inc.
Type
journal article